Gordon Murray It cannot stop working. As he is 80 years old, Murray is still developing new cars, not even the diagnosis of cancer, taking it away from the drafting table. One of the latest supercar in Gordon Murray Automotive – S1 LM – was developed as the same name was subject to chemotherapy.
Murray revealed the diagnosis of cancer earlier this summer. He was diagnosed with esophageal cancer in early 2024, which he and his doctors caught during routine theorizing. Murray went through chemotherapy, saying in an interview, “(R) The oncology doctor spent the best part of an hour in the passage of possible side effects with me and my wife before I started chemotherapy, and a boy, I got everything.”
Last July, Murray underwent a successful surgery in the key hole.
Throughout all this, he was working closely with the customer who cost the S1 LM, a salute to Murray F1 GTR. “I can say frankly that this has obtained it through cancer treatment,” said Phil Lee, CEO of GMA, at the Monterrey week event. “It was very focused; it has gone through long moments of chemotherapy, works alongside the customer, going away and keeping himself focusing, and this car is the birth of that.”
I expanded in this statements with journalists. “It is amazing how much he focused on private car things throughout the treatment. (I) is proud of what he did there, and of course he made it very special for the customer as well.”
The S1 LM relies on T.50 from GMA and comes from Gordon Murray’s special compounds, a section of the company dedicated to limited versions and private customer committees like this. For the first time in Monterrey alongside the Le Mans GTR, which is operating 24 cars more than just a modern experience on F1 GTR.
Lee tells us that GMA has a lot of cars in the pipeline. So Murray will not slow down any time soon.
Additional reports by Brian Sylvestero.
